Watch CBS News

Stanford doctor discusses FDA's delayed approval of Alzheimer's drug

CBS News Bay Area anchor Ryan Yamamoto talks with Dr. Michael Greicius, professor of neurology and neurological sciences at Stanford Medicine, about how donanemab is supposed to work, and why the FDA made the decision to pull back on approval for now
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.